Lupin Acquisition

'Lupin Acquisition' - 13 News Result(s)

  • Indian Pharma's Focus On Acquisitions To Limit Deleveraging: Fitch
    Business | Press Trust of India | Tuesday November 15, 2016
    New Delhi: In line with global trends in thepharmaceuticals sector, the focus of domestic drug firms on acquisitionsto consolidate their position will limit deleveraging for thetime being, rating agency Fitch has said. "The ongoing focus of the top Indian pharma companies' onselective acquisitions to limit deleveraging over the shortterm," Fitch...
    www.ndtv.com/business
  • Lupin Completes Acquisition of GAVIS Pharma
    Business | Press Trust of India | Wednesday March 9, 2016
    Drug major Lupin on Wednesday said it has completed the acquisition of privately-held, US-based GAVIS Pharmaceuticals LLC and Novel Laboratories (GAVIS).
    www.ndtv.com/business
  • Lupin, Gavis to Sell 2 Drugs for Deal Approval
    Business | Press Trust of India | Sunday February 21, 2016
    Homegrown drug major Lupin and Gavis Pharmaceuticals LLC, which the Indian firm announced to acquire in an $850-million deal last year, have agreed to divest two generic drugs as part of the US Federal Trade Commission's (FTC) requirement to complete the transaction.
    www.ndtv.com/business
  • Cipla to Acquire Two US Companies in $550 Million Deal
    Business | NDTV | Friday September 4, 2015
    Cipla on Friday announced the acquisition of two US-based drugmakers - InvaGen Pharma and Exelan Pharma - for $550 million in an all cash transaction. Cipla shares gained over 2 per cent in morning trade to top the 50-share Nifty index.
    www.ndtv.com/business
  • Lupin Looks to Revive US Growth With $880-Million GAVIS Deal
    Business | Thomson Reuters | Thursday July 23, 2015
    Lupin Ltd, India's third-largest drug maker by sales, is buying US peer GAVIS Pharmaceuticals LLC for $880 million (Rs 5,588 crore at $1 = Rs 63.5) in its largest ever acquisition, seeking to revive its flagging growth in the United States, its largest market.
    www.ndtv.com/business
  • Lupin Misses Q1 Estimates; Gavis Acquisition Fails to Excite Street
    Business | NDTV | Thursday July 23, 2015
    Lupin's managing director Nilesh Gupta blamed the slowdown in approvals in the US market for the muted growth during the quarter. Sale of generic drugs in the US stood at $180 million in the June quarter against estimates of $220 million, Lupin said.
    www.ndtv.com/business
  • Lupin Gains Over 2% on Russian Acquisition
    Business | NDTV | Friday July 3, 2015
    Analysts say Lupin can build upon small base of Biocom and can use its trade channels to cross sales its products thereby generating higher revenues.
    www.ndtv.com/business
  • Lupin Plans to Beef Up Branded Portfolio Through Alliances in FY16
    Business | Press Trust of India | Sunday June 28, 2015
    Pharmaceuticals major Lupin is looking at strengthening its branded portfolio by creating alliances and eyeing strategic brand acquisitions in US markets in 2015-16.
    www.ndtv.com/business
  • Lupin Gains 2% on Acquisition of Additional Stake in Pharma Dynamics
    Business | Tuesday March 17, 2015
    Lupin had earlier acquired 60 per cent stake in the South African (SA) firm in September, 2008.
    www.ndtv.com/business
  • Scouting For Acquisitions in India: Lupin
    Business | Sunday December 14, 2014
    The Mumbai-based firm, which is the fifth largest generic player in the US market, has so far stayed away from inorganic growth in India where it clocked revenues of Rs 2,479 crore in the previous fiscal.
    www.ndtv.com/business
  • Lupin Scouts for Acquisitions in US
    Business | Tuesday October 21, 2014
    Looking to bolster its overseas presence, drug major Lupin is scouting for acquisition opportunities in the US market, especially in inhalers and injectables segments.
    www.ndtv.com/business
  • Lupin Completes Acquisition of Mexico's Laboratories Grin
    Business | Wednesday October 1, 2014
    Drug firm Lupin Ltd has completed the acquisition of Mexico's Laboratories Grin, a player in the ophthalmic products segment.
    www.ndtv.com/business
  • Business | NDTV Correspondent | Wednesday November 23, 2011
    Lupin Ltd has informed BSE that Lupin Holdings B.V.. (LHBV) Netherlands, a wholly-owned subsidiary of the Company, was holding 49.91% equity stake in Generic Health Pty. Ltd. (Generic Health), Australia, an Associate of the Company. LHBV has now acquired a majority stake in the Generic Health on account of subscription to the right issue of shares....
    www.ndtv.com/business

'Lupin Acquisition' - 3 Video Result(s)

'Lupin Acquisition' - 13 News Result(s)

  • Indian Pharma's Focus On Acquisitions To Limit Deleveraging: Fitch
    Business | Press Trust of India | Tuesday November 15, 2016
    New Delhi: In line with global trends in thepharmaceuticals sector, the focus of domestic drug firms on acquisitionsto consolidate their position will limit deleveraging for thetime being, rating agency Fitch has said. "The ongoing focus of the top Indian pharma companies' onselective acquisitions to limit deleveraging over the shortterm," Fitch...
    www.ndtv.com/business
  • Lupin Completes Acquisition of GAVIS Pharma
    Business | Press Trust of India | Wednesday March 9, 2016
    Drug major Lupin on Wednesday said it has completed the acquisition of privately-held, US-based GAVIS Pharmaceuticals LLC and Novel Laboratories (GAVIS).
    www.ndtv.com/business
  • Lupin, Gavis to Sell 2 Drugs for Deal Approval
    Business | Press Trust of India | Sunday February 21, 2016
    Homegrown drug major Lupin and Gavis Pharmaceuticals LLC, which the Indian firm announced to acquire in an $850-million deal last year, have agreed to divest two generic drugs as part of the US Federal Trade Commission's (FTC) requirement to complete the transaction.
    www.ndtv.com/business
  • Cipla to Acquire Two US Companies in $550 Million Deal
    Business | NDTV | Friday September 4, 2015
    Cipla on Friday announced the acquisition of two US-based drugmakers - InvaGen Pharma and Exelan Pharma - for $550 million in an all cash transaction. Cipla shares gained over 2 per cent in morning trade to top the 50-share Nifty index.
    www.ndtv.com/business
  • Lupin Looks to Revive US Growth With $880-Million GAVIS Deal
    Business | Thomson Reuters | Thursday July 23, 2015
    Lupin Ltd, India's third-largest drug maker by sales, is buying US peer GAVIS Pharmaceuticals LLC for $880 million (Rs 5,588 crore at $1 = Rs 63.5) in its largest ever acquisition, seeking to revive its flagging growth in the United States, its largest market.
    www.ndtv.com/business
  • Lupin Misses Q1 Estimates; Gavis Acquisition Fails to Excite Street
    Business | NDTV | Thursday July 23, 2015
    Lupin's managing director Nilesh Gupta blamed the slowdown in approvals in the US market for the muted growth during the quarter. Sale of generic drugs in the US stood at $180 million in the June quarter against estimates of $220 million, Lupin said.
    www.ndtv.com/business
  • Lupin Gains Over 2% on Russian Acquisition
    Business | NDTV | Friday July 3, 2015
    Analysts say Lupin can build upon small base of Biocom and can use its trade channels to cross sales its products thereby generating higher revenues.
    www.ndtv.com/business
  • Lupin Plans to Beef Up Branded Portfolio Through Alliances in FY16
    Business | Press Trust of India | Sunday June 28, 2015
    Pharmaceuticals major Lupin is looking at strengthening its branded portfolio by creating alliances and eyeing strategic brand acquisitions in US markets in 2015-16.
    www.ndtv.com/business
  • Lupin Gains 2% on Acquisition of Additional Stake in Pharma Dynamics
    Business | Tuesday March 17, 2015
    Lupin had earlier acquired 60 per cent stake in the South African (SA) firm in September, 2008.
    www.ndtv.com/business
  • Scouting For Acquisitions in India: Lupin
    Business | Sunday December 14, 2014
    The Mumbai-based firm, which is the fifth largest generic player in the US market, has so far stayed away from inorganic growth in India where it clocked revenues of Rs 2,479 crore in the previous fiscal.
    www.ndtv.com/business
  • Lupin Scouts for Acquisitions in US
    Business | Tuesday October 21, 2014
    Looking to bolster its overseas presence, drug major Lupin is scouting for acquisition opportunities in the US market, especially in inhalers and injectables segments.
    www.ndtv.com/business
  • Lupin Completes Acquisition of Mexico's Laboratories Grin
    Business | Wednesday October 1, 2014
    Drug firm Lupin Ltd has completed the acquisition of Mexico's Laboratories Grin, a player in the ophthalmic products segment.
    www.ndtv.com/business
  • Business | NDTV Correspondent | Wednesday November 23, 2011
    Lupin Ltd has informed BSE that Lupin Holdings B.V.. (LHBV) Netherlands, a wholly-owned subsidiary of the Company, was holding 49.91% equity stake in Generic Health Pty. Ltd. (Generic Health), Australia, an Associate of the Company. LHBV has now acquired a majority stake in the Generic Health on account of subscription to the right issue of shares....
    www.ndtv.com/business

'Lupin Acquisition' - 3 Video Result(s)

Your search did not match any documents
A few suggestions
  • Make sure all words are spelled correctly
  • Try different keywords
  • Try more general keywords
Check the NDTV Archives:https://archives.ndtv.com